Sara M. A.
- Country
- Spain
- Department
- Rheumatology
Research Overview
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Ianalumab Efficacy, Safety, and Tolerability in Diffuse Cutaneous Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study
- Efficacy, Safety, and Tolerability of IMVT-1402 in ACPA-Positive Rheumatoid Arthritis: A Phase 2b Multicenter, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 72 of 150 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in the clinical research of Sjögren's Syndrome, with particular emphasis on patients experiencing systemic manifestations of the condition.
- Primary Sjögren's Syndrome management
- Systemic disease manifestations
- Moderate to severe disease activity
The investigator's therapeutic focus includes evaluating novel treatment approaches for systemic autoimmune conditions, particularly in cases where patients present with complex disease manifestations.
Therapeutic Innovation
Research interests center on investigating emerging immunomodulatory therapies for autoimmune disorders, with a focus on long-term treatment outcomes.
- Novel therapeutic agents
- Long-term safety assessment
- Treatment tolerability studies
The investigator's work encompasses comprehensive evaluation of therapeutic interventions for chronic autoimmune conditions.
Clinical Assessment
Expertise includes the evaluation of disease activity measures in autoimmune conditions, focusing on systemic manifestations and therapeutic responses.
- Disease activity monitoring
- Systemic manifestation assessment
- Treatment response evaluation
The investigator specializes in analyzing therapeutic outcomes in patients with complex autoimmune presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.